

Visitors
|
Satellite Symposium 1 (Handok) COPD |
Wednesday, October 28,
17:15 - 18:15 CRYSTAL 1 (3F) | Room 1 |
|
|---|---|---|
| Chair | Yeon-Mok Oh (University of Ulsan, Korea) | |
| 17:15-18:15 |
Treatable Traits : Toward Precision Medicine in COPD – From Concept to Clinical Implementation
Claus F. Vogelmeier (Philipps-University Marburg, Germany)
|
|
|
Satellite Symposium 2 (ILDONG PHARMACEUTICAL CO.,LTD.) ILD |
Wednesday, October 28,
17:15 - 18:15 CRYSTAL 3 (3F) | Room 3 |
|
| Chair | Yong Hyun Kim (The Catholic University of Korea, Korea) | |
| 17:15-18:15 |
Optimizing the Management of Idiopathic Pulmonary Fibrosis (IPF) Patients: Current and Emerging Therapies
Kevin Robert Flaherty (University of Michigan Health, USA)
|
|
|
Satellite Symposium 3 (GSK) COPD |
Thursday, October 29,
17:15 - 18:15 CRYSTAL 1 (3F) | Room 1 |
|
| Chair | Hyoung-Kyu Yoon (The Catholic University of Korea, Korea) | |
| 17:15-18:15 |
TBD
Chin Kook Rhee (Konkuk University, Korea)
|
|
|
Satellite Symposium 4 (MSD Korea) Infection |
Thursday, October 29,
17:15 - 18:15 CRYSTAL 2 (3F) | Room 2 |
|
| Chair | Sang-Min Lee (Seoul National University, Korea) | |
| 17:15-18:15 |
HAP/VAP with MDR Gram-Negative Pathogens
Su Yeon Lee (University of Ulsan, Korea)
|
|
|
Satellite Symposium 5 (AstraZeneca) Lung Cancer |
Thursday, October 29,
17:15 - 18:15 CRYSTAL 3 (3F) | Room 3 |
|
| Chair | In-Jae Oh (Chonnam National University, Korea) | |
| 17:15-18:15 |
From Evidence to Experience: How FLAURA2 Is Reshaping First-Line Treatment in EGFR-Mutated NSCLC
Seong Hoon Yoon (Pusan National University, Korea)
|
|
|
Satellite Symposium 6 (KOLON PHARMA) ILD |
Thursday, October 29,
17:15 - 18:15 EMERALD (3F) | Room 4 |
|
| Chair | Jong Sun Park (Seoul National University Bundang Hospital, Korea) | |
| 17:15-18:15 |
TBD
Ian Glaspole (The Alfred Hospital, Australia)
|
|